The distribution in colorectal cancer is under dispute, although previous studies have shown that between 50 and 68% of patients suffering from colorectal cancers expressed CD24 to a high extent [5], [6], and further that CD24 positive subpopulations from colon cancer cell-lines possess stem cell-like properties [7]. Here, CD24 is linked to malignant colon neoplasm.